Clinical update on benefit versus risks of oral paracetamol alone or with codeine: still a good option?

References

• PIC 2016. Paracetamol Information Centre. Available at: www.pharmweb.net [Last accessed 27 June 2016]
   Google Scholar
• O’Neil CK, Hanlon JT, Marcum ZA. Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics. Am J Geriatr Pharmacother 2012;10:331-42
   PubMed Web of Science ®Google Scholar
• Fulton RL, Walters MR, Morton R, et al. Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. Hypertension 2015;65:1008-14
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society. 2015 Updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2015;64:1-20
   Google Scholar
• WHO Model List of Essential Medicines, 19th Edition. 2015. Available at: http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf?ua=1 [Last accessed 20 July 2016]
   Google Scholar
• McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 2014;22:363-88
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 2012;64:465-74
   PubMed Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62
   PubMed Web of Science ®Google Scholar
• Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476-99
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 2007;66:377-88
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 2005;64:669-81
   PubMed Web of Science ®Google Scholar
• Worthington I, Pringsheim T, Gawel MJ, et al., Canadian Headache Society Acute Migraine Treatment Guideline Development Group. Canadian Headache Society Guideline: acute drug therapy for migraine headache. Can J Neurol Sci 2013;40(Suppl 3):S1-S80
   Google Scholar
• Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society Evidence Assessment of migraine pharmacotherapies. Headache 2015;55:3-20
   PubMed Web of Science ®Google Scholar
• NICE guidelines [CG177]: Osteoarthritis: care and management 2014. National Clinical Guideline Centre. Available at: https://www.nice.org.uk/guidance/cg177/evidence [Last accessed 20 July 2016]
   Google Scholar
• Brune K, Renner B, Tiegs G. Acetaminophen/paracetamol: a history of errors, failures and false decisions. Eur J Pain 2014;19:953-65
   PubMed Web of Science ®Google Scholar
• Roberts E, Delgado Nunes V, Buckner S, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis 2016;75:552-9
   PubMed Web of Science ®Google Scholar
• Wise J. True risks of paracetamol may be underestimated, say researchers. BMJ 2015;350:h1136
   Google Scholar
• Aminoshariae A, Khan A. Acetaminophen: old drug, new issues. J Endod 2015;41:588-93
   PubMed Web of Science ®Google Scholar
• Straube C, Derry S, Jackson KC, et al. Codeine, alone and with paracetamol (acetaminophen), for cancer pain. Cochrane Database Syst Rev 2014;9:CD006601
   Web of Science ®Google Scholar
• Heintze K, Fuchs W. Codeine ultra-rapid metabolizers: age appears to be a key factor in adverse effects of codeine. Drug Res (Stuttg) 2015;65:640-4
   PubMed Web of Science ®Google Scholar
• Review of Codeine Containing Medicines Started. European Medicines Agency, 2012. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Codeine_containing_medicinal_products/human_referral_prac_000008.jsp&mid=WC0b01ac05805c516f [Last accessed 20 July 2016]
   Google Scholar
• United States Food and Drug Administration. Drug Safety Communication. Safety Review Update of Codeine use in Children; A New Boxed Warning and Contraindication on Use after Tonsillectomy and or Adenoidectomy. United States Food and Drug Administration, 2013. Available at: www.fda.gov/Drugs/Drugsafety/ucm339112.htm [Last accessed 20 July 2016]
   Google Scholar
• Bond GR, Ho M, Woodward RW. Trends in hepatic injury associated with unintentional overdose of paracetamol (acetaminophen) in products with and without opioid. Drug Saf 2012;35:149-57
   PubMed Web of Science ®Google Scholar
• Larson AM, Polson J, Fontana RJ, et al.; Acute Liver Failure Study Group. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42:1364-72
   PubMed Web of Science ®Google Scholar
• Krenzelok EP. The FDA Acetaminophen Advisory Committee Meeting – what is the future of acetaminophen in the United States? The perspective of a committee member. Clin Toxicol (Phila) 2009;47:784-9
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services, Food and Drug Administration (Docket No. FDA–2011–N–0021) Prescription Drug Products Containing Acetaminophen; Actions To Reduce Liver Injury From Unintentional Overdose. Federal Register 2011;76, No. 10/Notices 2691
   Google Scholar
• Wehling M. Paracetamol. Efficacious and safe for all ages. Schmerz 2013;27:20-5
   PubMed Web of Science ®Google Scholar
• Petersen KU. Acetaminophen and the liver: damage at therapeutic dose levels? MMW-Fortschr Med 2011;153:137-42
   Google Scholar
• Twycross R, Pace V, Mihalyo M, Wilcock A. Therapeutic reviews: acetaminophen (paracetamol). J Pain Symptom Manage 2013;46:747
   PubMed Web of Science ®Google Scholar
• Prescott LF. Paracetamol (acetaminophen): a critical bibliographic review. London: Taylor & Francis, 1996
   Google Scholar
• Liukas A, Kuusniemi K, Aantaa R, et al. Pharmacokinetics of intravenous paracetamol in elderly patients. Clin Pharmacokinet 2011;50:121-9
   PubMed Web of Science ®Google Scholar
• Zhao L, Pickering G. Paracetamol metabolism and related genetic differences. Drug Metab Rev 2011;43:41-52
   PubMed Web of Science ®Google Scholar
• Dong H, Haining RL, Thummel KE, et al. Involvement of human cytochrome P4502D6 in the bioactivation of acetaminophen. Drug Metab Dispos 2000;28:1397-400
   PubMed Web of Science ®Google Scholar
• Miranda HF, Puig MM, Prieto JC, Pinardi G. Synergism between paracetamol and nonsteroidal antiinflammatory drugs in experimental acute pain. Pain 2006;121:22-8
   PubMed Web of Science ®Google Scholar
• Ong CK, Seymour RA, Lirk P, Merry AF. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg 2010;110:1170-9
   PubMed Web of Science ®Google Scholar
• Moore UJ, Seymour RA, Rawlins MD. The efficacy of locally applied aspirin and acetaminophen in postoperative pain after third molar surgery. Clin Pharmacol Ther 1992;52:292-6
   PubMed Web of Science ®Google Scholar
• Pini LA, Sandrini M, Vitale G. The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur J Pharmacol 1996;308:31-40
   PubMed Web of Science ®Google Scholar
• Choi SS, Lee JK, Suh HW. Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models. Brain Res 2001;921:233-9
   PubMed Web of Science ®Google Scholar
• Crawley B, Saito O, Malkmus S, et al. Acetaminophen prevents hyperalgesia in central pain cascade. Neurosci Lett 2008;442:50-3
   PubMed Web of Science ®Google Scholar
• Björkman R, Hallman K, Hedner J, et al. Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain 1994;57:259-64
   PubMed Web of Science ®Google Scholar
• Zygmunt PM, Chuang H, Movahed P, et al. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 2000;396:39-42
   PubMed Web of Science ®Google Scholar
• Kerckhove N, Mallet C, Francois A, et al. Cav3.2 calcium channels: the key protagonist in the supraspinal effect of paracetamol. Pain 2014;155:764-72
   PubMed Web of Science ®Google Scholar
• McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997;126:712-20
   PubMed Web of Science ®Google Scholar
• Acute pain Bandolier – evidenced based health care. Available at: http://www.medicine.ox.ac.uk/bandolier/Extraforbando/APain.pdf [Last accessed 1 October 2014]
   Google Scholar
• Moore RA, Moore OA, Derry S, McQuay HJ. Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores. Arthritis Res Ther 2008;10:R39
   PubMed Web of Science ®Google Scholar
• Straube S, Derry S, McQuay HJ, Moore RA. Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. Br J Clin Pharmacol 2008;66:266-75
   PubMed Web of Science ®Google Scholar
• Hyllested M, Jones S, Pedersen J, Kehlet H. Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review. Br J Anaesth 2002;88:199-214
   PubMed Web of Science ®Google Scholar
• Barden J, Edwards JE, McQuay HJ, et al. Relative efficacy of oral analgesics after third molar extraction. Br Dent J 2004;197:407-11
   PubMed Web of Science ®Google Scholar
• Moore RA, Straube S, Paine J, et al. Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. Pain 2011;152:982-9
   PubMed Web of Science ®Google Scholar
• Menhinick K, Gutmann J, Regan J, et al. The efficacy of pain control following nonsurgical root canal treatment using ibuprofen or a combination of ibuprofen and acetaminophen in a randomized, double-blind, placebo-controlled study. Int Endod J 2004;37:531-41
   PubMed Web of Science ®Google Scholar
• Wells LK, Drum M, Nusstein J, et al. Efficacy of ibuprofen and ibuprofen/acetaminophen on postoperative pain in symptomatic patients with a pulpal diagnosis of necrosis. J Endod 2011;37:1608-12
   PubMed Web of Science ®Google Scholar
• Bailey E, Worthington H, Coulthard P. Ibuprofen and/or paracetamol (acetaminophen) for pain relief after surgical removal of lower wisdom teeth, a Cochrane systematic review. Br Dent J 2014;216:451-5
   PubMed Web of Science ®Google Scholar
• Bailey E, Worthington HV, van Wijk A, et al. Ibuprofen and/or paracetamol (acetaminophen) for pain relief after surgical removal of lower wisdom teeth. Cochrane Database Syst Rev 2013;12:CD004624
   Web of Science ®Google Scholar
• Moore PA, Hersh EV. Combining ibuprofen and acetaminophen for acute pain management after third-molar extractions: translating clinical research to dental practice. J Am Dent Assoc 2013;144:898-908
   PubMed Web of Science ®Google Scholar
• Derry CJ, Derry S, Moore RA. Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain. Cochrane Database Syst Rev 2013;6:CD010210
   PubMedGoogle Scholar
• Elia N, Lysakowski C, Tramer MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology 2005;103:1296-304
   PubMed Web of Science ®Google Scholar
• Mason L, Edwards JE, Moore RA, McQuay HJ. Single-dose oral naproxen for acute postoperative pain: a quantitative systematic review. BMC Anesthesiol 2003;3:4
   PubMedGoogle Scholar
• Bandolier – evidenced based health care. Available at: http://www.medicine.ox.ac.uk/bandolier/booth/painpag/Acutrev/Analgesics/AP028.html [Last accessed 1 October 2014]
   Google Scholar
• Moore RA. Bandolier’s Little Book of Pain. New York: Oxford University Press, 2003
   Google Scholar
• Moore RA, Derry S, Wiffen PJ, et al. Evidence for efficacy of acute treatment of episodic tension-type headache: methodological critique of randomised trials for oral treatments. Pain 2014;155:2220-8
   PubMed Web of Science ®Google Scholar
• Stephens G, Derry S, Moore RA. Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev 2016;6:CD011889
   Web of Science ®Google Scholar
• Schachtel BP, Furey SA, Thoden WR. Nonprescription ibuprofen and acetaminophen in the treatment of tension-type headache. J Clin Pharmacol 1996;36:1120-5
   PubMed Web of Science ®Google Scholar
• Packman B, Packman E, Doyle G, et al. Solubilized ibuprofen: evaluation of onset, relief and safety of a novel formulation in the treatment of episodic tension-type headache. Headache 2000;40:561-7
   PubMed Web of Science ®Google Scholar
• Derry S, Wiffen PJ, Moore RA, et al. Ibuprofen for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev 2015;31:CD011474
   Google Scholar
• Rabbie R, Derry S, Moore RA. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;4:CD008039
   Web of Science ®Google Scholar
• Derry S, Moore RA. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;4:CD008040
   Google Scholar
• Termine C, Özge A, Antonaci F, et al. Overview of diagnosis and management of paediatric headache. Part II: therapeutic management. J Headache Pain 2011;12:25-34
   PubMed Web of Science ®Google Scholar
• Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev 2016;4:CD005220
   PubMedGoogle Scholar
• NICE Clinical Guidelines, CG150: Headaches: Diagnosis and Management of Headaches in Young People and Adults. National Clinical Guideline Centre (UK). London: Royal College of Physicians (UK) http://www.nice.org.uk/guidance/cg150 [Last accessed 20 July 2016]
   Google Scholar
• Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006;1:CD004257
   Web of Science ®Google Scholar
• Verkleij SP, Luijsterburg PA, Bohnen AM, et al. NSAIDs versus acetaminophen in knee and hip osteoarthritis: a systematic review regarding heterogeneity influencing the outcomes. Osteoarthritis Cartilage 2011;19:921-9
   PubMed Web of Science ®Google Scholar
• Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomized placebo controlled trials. BMJ 2015;350:h1225
   PubMed Web of Science ®Google Scholar
• Prior MJ, Harrison DD, Frustaci ME. A randomized, double-blind, placebo-controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis. Curr Med Res Opin 2014;30:2377-87
   PubMed Web of Science ®Google Scholar
• Lee C, Straus WL, Balshaw R, et al. A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis. Arthritis Rheum 2004;51:746-54
   PubMed Web of Science ®Google Scholar
• Williams CM, Maher CG, Latimer J, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet 2014;384:1586-96
   PubMed Web of Science ®Google Scholar
• Rainsford KD, Roberts SC, Brown S. Ibuprofen and paracetamol: relative safety in non-prescription dosages. J Pharm Pharmacol 1997;49:345-76
   PubMed Web of Science ®Google Scholar
• Doherty M, Hawkey C, Goulder M, et al. A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain. Ann Rheum Dis 2011;70:1534-41
   PubMed Web of Science ®Google Scholar
• Baigent C; Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013;382:769-79
   PubMed Web of Science ®Google Scholar
• Lee WM. Acute liver failure. Semin Respir Crit Care Med 2012;33:36-45
   PubMed Web of Science ®Google Scholar
• Claridge LC, Eksteen B, Smith A, et al. Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults. BMJ 2010;341:6764
   PubMed Web of Science ®Google Scholar
• Craig DG, Bates CM, Davidson JS, et al. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol induced hepatotoxicity. Br J Clin Pharmacol 2012;73:285-94
   PubMed Web of Science ®Google Scholar
• Acetaminophen safety – deja vu. Med Lett Drugs Ther 2009;51:53-4
   PubMed Web of Science ®Google Scholar
• von Mach MA, Hermanns-Clausen M, Koch I, et al. Experiences of a poison center network with renal insufficiency in acetaminophen overdose: an analysis of 17 cases. Clin Toxicol (Phila) 2005;43:31-7
   PubMed Web of Science ®Google Scholar
• Rumack B, Heard K, Green J, et al. The effect of acetaminophen on serum alanine aminotransferase activity in subjects who consume ethanol: a systematic review and meta-analysis of published randomized, controlled trials. Pharmacotherapy 2012;32:784-91
   PubMed Web of Science ®Google Scholar
• Rumack BH. Acetaminophen misconceptions. Hepatology 2004;40:10-15
   PubMed Web of Science ®Google Scholar
• Hayward KL, Powell EE, Irvine KM, Martin JH. Can paracetamol (acetaminophen) be administered to patients with liver impairment? Br J Clin Pharmacol 2015;81:210-22
   PubMed Web of Science ®Google Scholar
• Gomez-Moreno G, Guardia J, Cutando A. Interaction of paracetamol in chronic alcoholic patients. Importance for odontologists. Med Oral Patol Oral Cir Bucal 2008;13:E235-8
   PubMed Web of Science ®Google Scholar
• Riordan SM, Williams R. Alcohol exposure and paracetamol-induced hepatotoxicity. Addict Biol 2002;7:191-206
   PubMed Web of Science ®Google Scholar
• Dart RC, Bailey E. Does therapeutic use of acetaminophen cause acute liver failure? Pharmacotherapy 2007;27:1219-30
   PubMed Web of Science ®Google Scholar
• Benson GD, Koff RS, Tolman KG. The therapeutic use of acetaminophen in patients with liver disease. Am J Ther 2005;12:133-41
   PubMedGoogle Scholar
• Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 1995;22:767-73
   PubMed Web of Science ®Google Scholar
• Riley T 3rd, Bhatti AM. Preventive strategies in chronic liver disease: part I. Alcohol, vaccines, toxic medications and supplements, diet and exercise. Am Fam Physician 2001;64:1555-60
   PubMed Web of Science ®Google Scholar
• Dwyer JP, Jayasekera C, Nicoll A. Analgesia for the cirrhotic patient: a literature review and recommendations. J Gastroenterol Hepatol 2014;29:1356-60
   PubMed Web of Science ®Google Scholar
• Prescott L. Effects of non-narcotic analgesics on the liver. Drugs 1986;32:129-47
   PubMed Web of Science ®Google Scholar
• Jones AL. Recent advances in the management of late paracetamol poisoning. Emerg Med 2000;12:14-21
   Google Scholar
• O’connor N, Dargan PI, Jones AL. Hepatocellular damage from non-steroidal antiinflammatory drugs. QJM 2003;96:787-91
   PubMed Web of Science ®Google Scholar
• Graham GG, Davies MJ, Day RO, et al. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology 2013;21:201-32
   PubMed Web of Science ®Google Scholar
• Benson GD. Acetaminophen in chronic liver disease. Clin Pharmacol Ther 1983;33:95-101
   PubMed Web of Science ®Google Scholar
• Khalid SK, Lane J, Navarro V, Garcia-Tsao G. Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis. Clin Gastroenterol Hepatol 2009;7:994-9
   PubMed Web of Science ®Google Scholar
• Schilling A, Corey R, Leonard M, Eghtesad B. Acetaminophen: old drug, new warnings. Cleve Clin J Med 2010;77:19-27
   PubMed Web of Science ®Google Scholar
• Heard K, Green JL, Bailey JE, et al. A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol. Aliment Pharmacol Ther 2007;26:283-90
   PubMed Web of Science ®Google Scholar
• Kuffner EK, Green JL, Bogdan GM et al. The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients – a multicenter randomized study. BMC Med 2007;5:13
   PubMed Web of Science ®Google Scholar
• Horsmans Y, Sempoux C, Detry R, Geubel AP. Paracetamol-induced liver toxicity after intravenous administration. Liver 1998;18:294-5
   PubMedGoogle Scholar
• FDA. Liver injury related to the use of acetaminophen in both over-the-counter and prescription products. Advisory Committee Meeting (transcript). 2009. Available at: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm165107.htm [Last accessed 20 July 2016]
   Google Scholar
• FDA. Prescription acetaminophen products to be limited to 325 mg per dosage unit; boxed warning will highlight potential for severe liver failure. Drug Saf Commun 2011. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm239821.htm [Last accessed 27 July 2016]
   Google Scholar
• Kheradpezhouh E, Ma L, Morphett A, et al. TRPM2 channels mediate acetaminophen-induced liver damage. Proc Natl Acad Sci USA 2014;111:3176-81
   PubMed Web of Science ®Google Scholar
• MHRA. Paracetamol overdose: new guidance on treatment with intravenous acetylcysteine. Drug Safety Update 2012;6:A1
   Google Scholar
• Acetadote (acetylcysteine) package insert. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021539s012lbl.pdf [Last accessed 27 September 2013]
   Google Scholar
• British National Formulary Emergency treatment of poisoning. London: BMJ Group and Pharmaceutical Press. Available at: www.bnf.org [Last accessed 15 March 2013]
   Google Scholar
• Ferner RE, Dear JW, Bateman DN. Management of paracetamol poisoning. BMJ 2011;342:968-72
   Web of Science ®Google Scholar
• Sawdy R, Slater D, Fisk N, et al. Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet 1997;350:265-6
   PubMed Web of Science ®Google Scholar
• Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 1998;47(Suppl 2):S78-S87
   PubMed Web of Science ®Google Scholar
• Bessone F. Non-steroidal anti-inflammatory drugs: what is the actual risk of liver damage? World J Gastroenterol 2010;16:5651-61
   PubMed Web of Science ®Google Scholar
• Davidson DG, Eastham WN. Acute liver necrosis following overdose of paracetamol. Br Med J 1966;2:497-9
   PubMed Web of Science ®Google Scholar
• Mitchell JR, Jollow DJ, Potter WZ, et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 1973;187:185-94
   PubMed Web of Science ®Google Scholar
• Schapira D, Bassan L, Nahir AM, Scharf Y. Diclofenac-induced hepatotoxicity. Postgrad Med J 1986;62:63-5
   PubMed Web of Science ®Google Scholar
• Banks AT, Zimmerman HJ, Ishak KG, Harter JG. Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 1995;22:820-7
   PubMed Web of Science ®Google Scholar
• Walker AM. Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1997;40:201-8
   PubMed Web of Science ®Google Scholar
• Traversa G, Bianchi C, Da Cas R, et al. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. BMJ 2003;327:18-22
   PubMed Web of Science ®Google Scholar
• Castellsague J, Pisa F, Rosolen V, et al. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy. Pharmacoepidemiol Drug Saf 2013;22:365-75
   PubMed Web of Science ®Google Scholar
• Castellsague J, Riera-Guardia N, Calingaert B, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf 2012;35:1127-46
   PubMed Web of Science ®Google Scholar
• Gulmez SE, Larrey D, Pageaux GP, et al. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case–population SALT study. Drug Saf 2013;36:135-44
   PubMed Web of Science ®Google Scholar
• Kress HG, Baltov A, Basinski A, et al. Acute pain: a multifaceted challenge – the role of nimesulide. Curr Med Res Opin 2016;32:23-36
   PubMed Web of Science ®Google Scholar
• Rahme E, Barkun A, Nedjar H, et al. Hospitalizations for upper and lower GI events associated with traditional NSAIDs, and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol 2008;103:872-82
   PubMed Web of Science ®Google Scholar
• CMDh. Updated advice on use of high-dose ibuprofen. European Medicines Agency EMA/325007/2015. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2015/05/WC500187108.pdf [Last accessed 10 July 2016]
   Google Scholar
• Chan AT, Manson JE, Albert CM, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation 2006;113:1578-87
   PubMed Web of Science ®Google Scholar
• Sudano I, Flammer AJ, Périat D, et al. Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation 2010;122:1789-96
   PubMed Web of Science ®Google Scholar
• Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 2008;22:383-90
   PubMed Web of Science ®Google Scholar
• Antman EM, Bennett JS, Daugherty A, et al.; American Heart Association. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115:1634-42
   PubMed Web of Science ®Google Scholar
• Curry RW Jr, Robinson JD, Sughrue MJ. Acute renal failure after acetaminophen ingestion. JAMA 1982;247:1012-14
   PubMed Web of Science ®Google Scholar
• Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestation, and management. J Med Toxicol 2008;4:2-6
   PubMedGoogle Scholar
• Werler MM, Mitchell A, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 2005;193:771-7
   PubMed Web of Science ®Google Scholar
• Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 9th edn. Philadelphia, PA: Lippincott Williams and Wilkins, 2011
   Google Scholar
• Tylenol professional product information. McNeil Consumer Healthcare, 2010
   Google Scholar
• Thiele K, Kessler T, Arck P, et al. Acetaminophen and pregnancy: short- and long-term consequences for mother and child. J Reprod Immunol 2013;97:128-39
   PubMed Web of Science ®Google Scholar
• Liew Z, Ritz B, Rebordosa C, et al. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr 2014;168:313-20
   PubMed Web of Science ®Google Scholar
• Brandlistuen RE, Ystrom E, Nulman I, et al. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol 2013;42:1702-13
   PubMed Web of Science ®Google Scholar
• Sordillo JE, Scirica CV, Rifas-Shiman SH, et al. Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children. J Allergy Clin Immunol 2015;135:441-8
   PubMed Web of Science ®Google Scholar
• Shaheen SO, Newson RB, Ring SM et al. Prenatal and infant acetaminophen exposure, antioxidant gene polymorphisms, and childhood asthma. J Allergy Clin Immunol 2010;126:1141-8
   PubMed Web of Science ®Google Scholar
• Eyers S, Weatherall M, Jefferies S, Beasley R. Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin Exp Allergy 2011;41:482-9
   PubMed Web of Science ®Google Scholar
• Shaheen S, Newson R, Sherriff A, et al. Paracetamol use in pregnancy and wheezing in early childhood. Thorax 2002;57:958-63
   PubMed Web of Science ®Google Scholar
• Scialli AR, Ang R, Breitmeyer J, Royal MA. Childhood asthma and use during pregnancy of acetaminophen. A critical review. Reprod Toxicol 2010;30:508-19
   PubMed Web of Science ®Google Scholar
• Albert O, Desdoits-Lethimonier C, Lesné L, et al. Paracetamol, aspirin and indomethacin display endocrine disrupting properties in the adult human testis in vitro. Hum Reprod 2013;28:1890-8
   PubMed Web of Science ®Google Scholar
• Colborn T. Neurodevelopment and endocrine disruption. Environ Health Perspect 2004;112:944-9
   PubMed Web of Science ®Google Scholar
• Howdeshell KL. A model of the development of the brain as a construct of the thyroid system. Environ Health Perspect 2002;110:337-48
   PubMed Web of Science ®Google Scholar
• Rubinow DR, Schmidt PJ. Androgens, brain, and behavior. Am J Psychiatry 1996;153:974-84
   PubMed Web of Science ®Google Scholar
• Jensen MS, Rebordosa C, Thulstrup AM, et al. Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiology 2010;21:779-85
   PubMed Web of Science ®Google Scholar
• Cheelo M, Lodge CJ, Dharmage SC, et al. Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a systematic review and meta-analysis. Arch Dis Child 2015;100:81-9
   PubMed Web of Science ®Google Scholar
• Heintze K, Petersen KU. The case of drug causation of childhood asthma: antibiotics and paracetamol. Eur J Clin Pharmacol 2013;69:1197-209
   PubMed Web of Science ®Google Scholar
• Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA). EMA/PRAC/324055/2014 [Last accessed 20 July 2016]
   Google Scholar
• Cooper M, Langley K, Thapar A. Antenatal acetaminophen use and attention-deficit/hyperactivity disorder: an interesting observed association but too early to infer causality. JAMA Pediatr 2014;168:306-7
   PubMed Web of Science ®Google Scholar
• Health and Social Care Information Centre, Prescribing, Primary Care. Prescription Cost Analysis, England 2012. The Health and Social Care Information Centre, 2013
   Google Scholar
• Cascarbi I. Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication. Eur J Clin Investig 2003;33(Suppl 2):17-22
   Web of Science ®Google Scholar
• Derry S, Moore RA, McQuay HJ. Single dose oral codeine, as a single agent, for acute postoperative pain in adults. Cochrane Database Syst Rev 2010;4:CD008099
   Google Scholar
• Edwards JE, McQuay HJ, Moore RA. Combination analgesic efficacy: individual patient data meta-analysis of single-dose oral tramadol plus acetaminophen in acute postoperative pain. J Pain Symptom Manage 2002;23:121-30
   PubMed Web of Science ®Google Scholar
• Toms L, Derry S, Moore RA, McQuay HJ. Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. Cochrane Database Syst Rev 2011;1:CD001547
   PubMedGoogle Scholar
• Tzortzopoulou A, McNicol ED, Cepeda MS, et al. Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain. Cochrane Database Syst Rev 2011;10:CD007
   Web of Science ®Google Scholar
• Axelsson B, Christensen S. Is there an additive analgesic effect of paracetamol at step 3? A double-blind randomized controlled study. Palliat Med 2003;17:724-5
   PubMed Web of Science ®Google Scholar
• Israel FJ, Parker G, Charles M, Reymond L. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage 2010;39:548-54
   PubMed Web of Science ®Google Scholar
• Formby FT. Re: Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients. J Pain Symptom Manage 2010;40:e6, author reply e6-7
   Google Scholar
• Stockler M, Vardy J, Pillai A, Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol 2004;22:3389-94
   PubMed Web of Science ®Google Scholar
• Moore RA, Derry S, McQuay HJ, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database Syst Rev 2011;9:CD008659
   Web of Science ®Google Scholar
• World Health Organization. WHO Cancer Pain Relief – a guide to opioid availability, 2nd edn. Geneva: WHO, 1996
   Google Scholar
• Franceschi F, Iacomini P, Marsiliani D, et al. Safety and efficacy of the combination acetaminophen–codeine in the treatment of pain of different origin. Eur Rev Med Pharmacol Sci 2013;17:2129-35
   PubMed Web of Science ®Google Scholar
• Rodriguez RF, Castillo JM, Del Pilar Castillo M, et al. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study. Clin Ther 2007;29:581-7
   PubMed Web of Science ®Google Scholar
• Tassinari D, Drudi F, Rosati M, et al. The second step of the analgesic ladder and oral tramadol in the treatment of mild to moderate cancer pain: a systematic review. Palliat Med 2011;25:410-23
   PubMed Web of Science ®Google Scholar
• Corsinovi L, Martinelli E, Fonte G, et al. Efficacy of oxycodone/acetaminophen and codeine/acetaminophen vs. conventional therapy in elderly women with persistent, moderate to severe osteoarthritis-related pain. Arch Gerontol Geriatr 2009;49:378-82
   PubMed Web of Science ®Google Scholar
• Colini Baldeschi G, Cobianchi MR. Study of codeine–paracetamol combination treatment compared with tramadol-paracetamol in the control of moderate-to-severe low back pain. Minerva Med 2012;103:177-82
   PubMed Web of Science ®Google Scholar
• Moore RA, Straube S, Aldington D. Pain measures and cut-offs – "no worse than mild pain" as a simple, universal outcome. Anaesthesia 2013;68:400-12
   PubMed Web of Science ®Google Scholar
• Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002;42(Suppl 1):3-9
   PubMed Web of Science ®Google Scholar
• Kress HG, Ahlbeck K, Aldington D, et al. Managing chronic pain in elderly patients requires a CHANGE of approach. Curr Med Res Opin 2014;30:1153-64
   PubMed Web of Science ®Google Scholar